GENEVA, Switzerland — A Covid-19 vaccine effective against multiple variants is possible before the end of 2022, the head of US pharmaceutical giant Pfizer said Wednesday. Chairman Albert Bourla said the firm was also working on producing a vaccine that could provide good protection for a whole year, meaning people ...